Abstract
Aim: Some evidence points at the role of soluble receptor for advanced glycation end products (sRAGE) in restenosis pathogenesis. The objective of the present study was to define whether the occurrence of restenosis after drug-eluting stent (DES) implantation for stable angina pectoris (AP) is associated with different circulating levels of sRAGE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
